E-Noses Promising for Diagnosing Cancer from Exhaled Breath
Electronic noses detect volatile organic compounds in exhaled breath to diagnose cancer.
Electronic noses detect volatile organic compounds in exhaled breath to diagnose cancer.
Women in low-income populations may be at a higher risk of breast cancer mortality due to access barriers. How has COVID-19 affected their ability to get breast cancer screenings?
Chronic myeloid leukemia (CML) can be painful and life-threatening if it is not caught in time. How can you educate patients with symptoms or who are newly diagnosed about the detection, symptoms, risk factors, and treatment of CML?
The approval was based on efficacy and safety data from 2 prospective clinical trials.
Results are provided within 15 minutes and can be read directly from the testing card.
Using a blood sample, the test is able to analyze more than 300 cancer-associated genes for alterations.
Currently, most tests rely on complex laboratory procedures, such as polymerase chain reaction.
Serology tests were better at detecting the presence of antibodies to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients when they were tested 15 to 35 days post-symptom onset, according to the findings of a recently published review on the Cochrane Database of Systematic Reviews.
Black, Hispanic patients less likely to receive recommended imaging at time of diagnosis of NSCLC.
[OncoTargets and Therapy] PLELC is a rare and distinct subtype of NSCLC associated with Epstein-Barr virus infection. Usually detected at early stage, prognosis is better for patients with PLELC than for those with other subtypes of NSCLC. This review discusses etiology, diagnosis, and treatment of the disease.